Like many European countries, the Republic of Lithuania has adopted a life-course immunisation calendar. This means that certain vaccines are recommended at certain stages of life in this Baltic Region country.
One of these focused vaccines is the Human Papillomavirus (HPV) vaccine.
As of July 2025, the Lithuanian Human Papillomavirus Vaccination Dashboard is believed to be the first to present vaccination history with a geographical perspective.
Lithuania Displays HPV Vaccination Data
Flu Shots to Remove Thimerosal
Health and Human Services Secretary Kennedy has signed the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommendations to remove the mercury-based preservative thimerosal from all influenza vaccines distributed in the United States.
This marks the final step in removing mercury from all vaccines administered to Americans.
Physicians Exiting Traditional Medicare Accelerated From 2010 to 2023
Rates higher during and since the pandemic, particularly among primary care physicians
Bio-Surveillance at International Airports Display Real-Time Disease Insights
The rising number of arboviral outbreaks worldwide in 2025 underscores the urgent need for enhanced preparedness and response systems.
Approximately five billion people are estimated to be at risk of Aedes-borne arbovirus infections, and 700,000 deaths are estimated to occur annually due to arbovirus-related diseases.
Mosquito-transmitted diseases such as chikungunya, dengue, and Zika not only burden healthcare systems but also lead to significant morbidity, mortality, and economic losses.
Bio-Surveillance at International Airports Display Disease Insights
The rising number of arboviral outbreaks worldwide in 2025 underscores the urgent need for enhanced preparedness and response systems.
Approximately five billion people are estimated to be at risk of Aedes-borne arbovirus infections, and 700,000 deaths are estimated to occur annually due to arbovirus-related diseases.
Mosquito-transmitted diseases such as chikungunya, dengue, and Zika not only burden healthcare systems but also lead to significant morbidity, mortality, and economic losses.
In Europe, Vaccines Can Prevent Sexually Transmitted Infections
Sexually transmitted infections (STIs) are increasingly spreading across Europe during the summer of 2025.
Every day, approximately one million people worldwide contract an STI.
The European Centre for Disease Prevention and Control (ECDC) has recently urged individuals at risk to stay informed about available vaccine options. In addition to chlamydia and syphilis, vaccines are available for gonorrhea, HPV, and mpox.
Vaccines Can Prevent Sexually Transmitted Infections in Europe
Sexually transmitted infections (STIs) are increasingly spreading across Europe during the summer of 2025.
Every day, approximately one million people worldwide contract an STI.
The European Centre for Disease Prevention and Control (ECDC) has recently urged individuals at risk to stay informed about available vaccine options. In addition to chlamydia and syphilis, vaccines are available for gonorrhea, HPV, and mpox.
2020 to 2024 Saw Drop in Flu Vaccine Uptake Among U.S. Adults
Biggest declines seen in populations usually associated with higher vaccine uptake
Ending Tetanus, Diphtheria Booster for Adults Could Save $1 Billion
The United States could safely reduce the frequency of tetanus and diphtheria booster shots for adults and save an estimated $1 billion per year, according to a new review led by researchers at Oregon Health & Science University.
This conclusion depends on the U.S. maintaining very high childhood vaccination rates.
Vaccines for tetanus and diphtheria are referred to as “legacy” vaccines by the healthcare industry because they were developed in the 1920s, during a time when the U.S. Food and Drug Administration was in its early stages of development.
Chikungunya Infection May Lead to Long-Term Joint Pain
The Chikungunya virus, transmitted by mosquitoes, has emerged as a significant global health concern. Recent outbreaks have spread beyond their usual regions in Africa and Asia to areas such as the Region of the Americas, China, France, and India.
Although the acute febrile illness typically resolves within a few days, many patients experience prolonged joint pain and arthritis.
This can severely impact their quality of life and place a burden on healthcare resources.